Sagimet Biosciences Inc.

For the period ended Jun 5, 2024. Filed Apr 18, 2024.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 5, 2024 · Filed Apr 18, 2024

SGMT$9.85+8.0%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

PROXY STATEMENT iv

	EQUITY COMPENSATION PLAN INFORMATION					39
	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT					40
	ITEMS TO BE VOTED ON					43
	PROPOSAL 1: ELECTION OF CLASS I DIRECTORS FOR A THREE-YEAR TERM EXPIRING IN 2027					43
	PROPOSAL 2: RATIFICATION OF APPOINTMENT OF Deloitte & Touche LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2024					44
	OTHER INFORMATION					45
	OTHER MATTERS					45
	REQUIREMENTS FOR SUBMISSION OF STOCKHOLDER PROPOSALS FOR NEXT YEAR’S ANNUAL MEETING					45
	STOCKHOLDER COMMUNICATIONS TO THE BOARD					45
	AVAILABILITY OF MATERIALS					46

PROXY STATEMENT

This Proxy Statement, with the enclosed proxy card, is being furnished to stockholders of the Company in connection with the solicitation by our Board of proxies to be voted at our Annual Meeting and at any postponements or adjournments thereof. The Annual Meeting will be held on Wednesday, June 5, 2024, at 10:00 a.m., Pacific Time, via the internet at https://web.lumiconnect.com/217605655, using the password sagimet2024.

This Proxy Statement and the enclosed proxy card are first being furnished to our stockholders on or about April 18, 2024. The Notice of Internet Availability of Proxy Materials being mailed to the stockholders is not part of the Proxy Statement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.